Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (205) 205
humans (149) 149
microbiology (111) 111
infectious diseases (83) 83
pharmacology & pharmacy (62) 62
microbial sensitivity tests (58) 58
female (57) 57
male (54) 54
epidemiology (49) 49
animals (47) 47
european union (47) 47
anti-bacterial agents - pharmacology (46) 46
antimicrobial resistance (43) 43
adult (42) 42
middle aged (41) 41
antibiotics (40) 40
surveillance (40) 40
antifungal agents - pharmacology (38) 38
resistance (37) 37
drug resistance (36) 36
bacteria (35) 35
european committee (33) 33
infections (33) 33
drug resistance, bacterial (31) 31
aged (30) 30
analysis (28) 28
prevalence (28) 28
medicine (27) 27
drug resistance in microorganisms (26) 26
microbial sensitivity tests - methods (25) 25
research (25) 25
adolescent (24) 24
health aspects (24) 24
hospitals (24) 24
susceptibility (24) 24
anti-bacterial agents - therapeutic use (23) 23
antimicrobial agents (23) 23
candida - drug effects (23) 23
europe (23) 23
immunology (21) 21
risk factors (21) 21
risk-factors (21) 21
research article (19) 19
child (18) 18
european committee on antimicrobial susceptibility testing (18) 18
multidisciplinary sciences (18) 18
amphotericin-b (17) 17
antibiotic-resistance (17) 17
bacterial infections and mycoses (17) 17
drugs (17) 17
laboratories (17) 17
life sciences (17) 17
young adult (17) 17
aged, 80 and over (16) 16
genes (16) 16
genetic aspects (16) 16
infection (16) 16
mycology (16) 16
science (16) 16
antifungal agents (15) 15
antimicrobial susceptibility (15) 15
bacteria - drug effects (15) 15
drug resistance, fungal (15) 15
fluconazole (15) 15
genotype (15) 15
microbial sensitivity tests - standards (15) 15
public health (15) 15
breakpoints (14) 14
child, preschool (14) 14
eucast (14) 14
pathogens (14) 14
usage (14) 14
voriconazole (14) 14
blood-stream infections (13) 13
echinocandins - pharmacology (13) 13
european continental ancestry group (13) 13
minimum inhibitory concentration (13) 13
pharmacology (13) 13
antifungal susceptibility (12) 12
children (12) 12
escherichia-coli (12) 12
infant (12) 12
mortality (12) 12
triazoles - pharmacology (12) 12
antibiotic resistance (11) 11
candida (11) 11
candida - isolation & purification (11) 11
clinical and laboratory standards institute (11) 11
diagnosis (11) 11
efficacy (11) 11
european continental ancestry group - genetics (11) 11
fluconazole - pharmacology (11) 11
infectious disease (11) 11
medical and health sciences (11) 11
medical microbiology (11) 11
medicin och hälsovetenskap (11) 11
medicine and health sciences (11) 11
mutation (11) 11
polymorphism, single nucleotide (11) 11
antimicrobials (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland
by Orasch, C and Marchetti, O and Garbino, J and Schrenzel, J and Zimmerli, S and Mühlethaler, K and Pfyffer, G and Ruef, C and Fehr, J and Zbinden, R and Calandra, T and Bille, J and Fungal Infect Network Switzerland and FUNGINOS
Clinical Microbiology and Infection, ISSN 1198-743X, 07/2014, Volume 20, Issue 7, pp. 698 - 705
We analyzed the species distribution of blood isolates (CBIs), prospectively collected between 2004 and 2009 within FUNGINOS, and compared their antifungal... 
Breakpoint | European Committee on Antimicrobial Susceptibility Testing | species | Candida | candidaemia | Clinical and Laboratory Standards Institute | resistance | uropean Committee on Antimicrobial Susceptibility Testing | andida | Resistance | Candidaemia | Clinical and laboratory standards institute | European committee on antimicrobial susceptibility testing | Species | VORICONAZOLE | INFECTIOUS DISEASES | MULTICENTER | HOSPITALS | MICROBIOLOGY | SECULAR TRENDS | FUNGEMIA | DENMARK | SURVEILLANCE | AGENTS | FLUCONAZOLE | EPIDEMIOLOGY | Antifungal Agents - pharmacology | Candidemia - microbiology | Fluconazole - pharmacology | Prospective Studies | Voriconazole - pharmacology | Candidemia - epidemiology | Candida - isolation & purification | Microbial Sensitivity Tests | Candida - classification | Switzerland - epidemiology | Candida - drug effects | Drug Resistance, Fungal | Lipopeptides | Echinocandins - pharmacology | Surveys | Mycoses | Fluconazole | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: A cross-sectional study
by Kassim, Ali and Omuse, Geoffrey and Premji, Zul and Revathi, Gunturu
Annals of Clinical Microbiology and Antimicrobials, ISSN 1476-0711, 04/2016, Volume 15, Issue 1, pp. 21 - 21
Background: The Clinical Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines are the... 
Clinical Laboratory Standards Institute (CLSI) | European Committee on Antimicrobial Susceptibility Testing (EUCAST) | Minimum inhibitory concentrations (MIC) | Antimicrobial susceptibility testing (AST) | CLSI | MICROBIOLOGY | Laboratories, Hospital - organization & administration | Microbial Sensitivity Tests - standards | Cross-Sectional Studies | Escherichia coli - drug effects | Humans | Hospitals, Teaching | Anti-Bacterial Agents - pharmacology | Pseudomonas aeruginosa - drug effects | Kenya | Staphylococcus aureus - drug effects | Microbial Sensitivity Tests - methods | Laboratories, Hospital - standards | Antibiotics | Comparative analysis | Medical laboratories | Analysis | Standards | Microbiology | Antimicrobial agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories
by Matuschek, E and Brown, D.F.J and Kahlmeter, G
Clinical Microbiology and Infection, ISSN 1198-743X, 04/2014, Volume 20, Issue 4, pp. O255 - O266
With the support of ESCMID and European countries, EUCAST has developed a disk diffusion test with zone diameter breakpoints correlated with the EUCAST... 
Antimicrobial susceptibility testing | Mueller–Hinton agar | disk diffusion | European Committee on Antimicrobial Susceptibility Testing | zone diameter breakpoints | MIC | inton agar | ueller | ommittee on | uropean | usceptibility | esting | ntimicrobial | Disk diffusion | European committee on antimicrobial susceptibility testing | Zone diameter breakpoints | Mueller-Hinton agar | INFECTIOUS DISEASES | MICROBIOLOGY | BREAKPOINTS | Bacteria - isolation & purification | Microbial Sensitivity Tests - standards | Europe | Humans | Bacteria - drug effects | Anti-Bacterial Agents - pharmacology | Bacterial Infections - diagnosis | Microbial Sensitivity Tests - methods | Microbiology | Laboratories | Analysis | Methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Clinical and laboratory standards institute versus European committee for antimicrobial susceptibility testing guidelines for interpretation of carbapenem antimicrobial susceptibility results for Escherichia coli in urinary tract infection (UTI)
by Sahu, Chinmoy and Jain, Vidhi and Mishra, Prabhakar and Prasad, Kashi Nath
Journal of laboratory physicians, ISSN 0974-2727, 07/2018, Volume 10, Issue 3, pp. 289 - 293
Carbapenems show excellent activity against resistant uropathogens, and they are the antibiotics of choice for urinary tract infections (UTIs). The choice of... 
Urinary tract infections | Antibiotics | Health aspects | Standards | Urine | Laboratories | Antimicrobial agents | Drug resistance | Epidemiology | Accuracy | E coli | Surveillance | Agreements | Urogenital system | Carbapenem | European Committee on antimicrobial susceptibility testing | Clinical and Laboratory Standards Institute | interpretation | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil
by Purisco, Sonia U and Martins, Marilena A and Szeszs, Maria W and Castro e Silva, Dulcilena M and Pukinskas, Sandra R.B.S and Bonfietti, Lucas X and Baez, Andres A and Melhem, Marcia S.C
FEMS Yeast Research, ISSN 1567-1356, 12/2012, Volume 12, Issue 8, pp. 890 - 896
Abstract We aim in this study to provide levels of susceptibility of 162 bloodstream isolates of non-Candida albicans and non-C. tropicalis species from a... 
Clinical and Laboratory Standards Institute (CLSI) | candidemia agents | EUCAST | uropean | usceptibility | esting | antifungal drugs | ommittee of | Candidemia agents | European Committee of Susceptibility Testing | Antifungal drugs | SPECIES DISTRIBUTION | INFECTIONS | MICROBIOLOGY | ANTIFUNGAL SUSCEPTIBILITY | PARAPSILOSIS | TECHNICAL NOTE | European Committee of Susceptibility Testing (EUCAST) | INTENSIVE-CARE-UNIT | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | AZOLE RESISTANCE | SURVEILLANCE | MYCOLOGY | EPIDEMIOLOGY | INVASIVE CANDIDIASIS | Antifungal Agents - pharmacology | Candidemia - microbiology | Fluconazole - pharmacology | Pichia - isolation & purification | Pichia - drug effects | Tertiary Care Centers | DNA, Fungal - genetics | Drug Resistance, Fungal - drug effects | Humans | Amphotericin B - pharmacology | Blood - microbiology | Pyrimidines - pharmacology | Candida - isolation & purification | Itraconazole - pharmacology | Triazoles - pharmacology | Candida - classification | Candidemia - drug therapy | Voriconazole | Brazil | Candida - drug effects | Pichia - classification | Microbial Sensitivity Tests - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Breakpoint to MIC quotient: A parameter to rapidly evaluate the in vitro bactericidal activity of β-lactams on Enterobacteriaceae
by Grillon, Antoine and Chabaud, Angeline and Zambardi, Gilles and Caniaux, Isabelle and Jehl, François
International Journal of Antimicrobial Agents, ISSN 0924-8579, 05/2019, Volume 53, Issue 5, pp. 674 - 677
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) do not completely predict the bactericidal nature of the antimicrobial... 
Minimum Inhibitory Concentration | Minimum Bactericidal Concentration | Breakpoint to MIC quotient | European Committee on Antimicrobial Susceptibility Testing | Etest | Enterobacteriaceae | Susceptibility Testing | INFECTIOUS DISEASES | IMPACT | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | European Committee on Antimicrobial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text From CLSI to EUCAST, a necessary step in Spanish laboratories
by Larrosa, María Nieves and Benito, Natividad and Cantón, Rafael and Canut, Andrés and Cercenado, Emilia and Fernández-Cuenca, Felipe and Guinea, Jesús and López-Navas, Antonio and Moreno, Miguel Ángel and Oliver, Antonio and Martínez-Martínez, Luis
Enfermedades Infecciosas y Microbiologia Clinica, ISSN 0213-005X, 2018
The Spanish Antibiogram Committee (Comité Español del Antibiograma, COESANT) presents in this document a simple “roadmap” or decalogue of recommendations, with... 
CLSI | EUCAST | European Committee on Antimicrobial Susceptibility Testing | MIC | Antimicrobial susceptibility testing | Clinical and Laboratory Standards Institute | Spanish Antibiogram Committee | Zone diameter breakpoints
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Bad bug, no test: Tigecycline susceptibility testing challenges and way forward
by Shankar, Chaitra and Pragasam, Agila and Veeraraghavan, Balaji and Amladi, Anushree
Indian Journal of Medical Microbiology, ISSN 0255-0857, 01/2019, Volume 37, Issue 1, pp. 91 - 94
Tigecycline is a reserve antibiotic increasingly used for the treatment of multidrug-resistant bacteria, especially Klebsiella pneumoniae and Acinetobacter... 
Pneumonia | Bacterial pneumonia | Klebsiella | Breakpoints | Regulatory agencies | Automation | Test procedures | Infections | Pharmacology | Drug resistance | Antiinfectives and antibacterials | Antibiotics | E coli | Surveillance | Gram-negative bacteria | Tigecycline | Drug dosages | Acinetobacter baumannii | European Committee on Antimicrobial Susceptibility Testing | interpretation | tigecycline | Klebsiella pneumoniae
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effects of clinical breakpoint changes in transition from clsi to eucast for antibiotic susceptibility test reporting of pseudomonas aeruginosa isolates: A local study in Turkey
by Sezgin, Fikriye Milletli and Acalagoz, Gorkemayt
Acta Medica Mediterranea, ISSN 0393-6384, 2017, Volume 33, Issue 2, pp. 285 - 290
Introduction: The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is a standard used for the implementation and evaluation of antibiotic... 
Clinical Laboratory Standards Institute (CLSI) | Pseudomonas aeruginosa | Antimicrobial susceptibility tests | European Committee on Antimicrobial Susceptibility Testing (EUCAST) | MORTALITY | MEDICINE, GENERAL & INTERNAL | IMPACT | RISK-FACTORS | BACTEREMIA | GUIDELINES | antimicrobial susceptibility tests | ANTIMICROBIAL RESISTANCE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam
by Cheng, Nai-Cheng and Liu, Chia-Ying and Huang, Yu-Tsung and Liao, Chun-Hsing and Teng, Lee-Jene and Hsueh, Po-Ren
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 06/2012, Volume 67, Issue 6, pp. 1413 - 1421
To investigate the in vitro susceptibility of ertapenem-non-susceptible Enterobacteriaceae (ENSE) isolates to cefotaxime, ceftazidime, cefepime and aztreonam.... 
Clinical and Laboratory Standards Institute | European Committee on Antimicrobial Susceptibility Testing | Third- and fourth-generation cephalosporins | Susceptibility breakpoints | Guidelines | MOLECULAR CHARACTERIZATION | INFECTIOUS DISEASES | KLEBSIELLA-PNEUMONIAE CARBAPENEMASE | EXTENDED-SPECTRUM | INTRAABDOMINAL INFECTIONS WORLDWIDE | MICROBIOLOGY | BETA-LACTAMASE | ANTIMICROBIAL RESISTANCE TRENDS | guidelines | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | PHARMACOLOGY & PHARMACY | third- and fourth-generation cephalosporins | SMART | EPIDEMIOLOGY | susceptibility breakpoints | NEW-YORK | Microbial Sensitivity Tests | beta-Lactams - pharmacology | Enterobacteriaceae Infections - microbiology | Humans | Enterobacteriaceae - drug effects | Hospitals, Teaching | Taiwan | Anti-Bacterial Agents - pharmacology | Enterobacteriaceae - isolation & purification | Proteins | Chemotherapy | Gram-negative bacteria | Antibiotics | Drug resistance | Index Medicus | Breakpoints | beta -Lactamase | Antimicrobial activity | Hospitals | Cefepime | Cefotaxime | Aztreonam | Minimum inhibitory concentration | Agar | Clinical isolates | Ceftazidime | ertapenem
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. The Comparison of Antibiotic Susceptibilities of Uropathogenic Escherichia coli Isolates in Transition from CLSI to EUCAST
by Suzuk, S and Kaskatepe, B and Avcikucuk, H and Aksaray, S and Basustaoglu, A
MIKROBIYOLOJI BULTENI, ISSN 0374-9096, 10/2015, Volume 49, Issue 4, pp. 494 - 501
Determination of treatment protocols for infections according to antimicrobial susceptibility test (AST) results is are important for controlling the problem... 
CLINICAL BREAKPOINT CHANGES | ANTIMICROBIAL SUSCEPTIBILITY | IMPACT | antibiotic susceptibility test | GUIDELINES | Clinical Laboratory Standards Institute (CLSI) | RESISTANCE | MICROBIOLOGY | European Committee on Antimicrobial Susceptibility Testing (EUCAST) | Esherichia coli | Humans | Bacteriuria - microbiology | Drug Resistance, Bacterial | Cefuroxime - pharmacology | Sulbactam - pharmacology | Levofloxacin - pharmacology | Anti-Bacterial Agents - therapeutic use | Reference Standards | Microbial Sensitivity Tests - standards | Gentamicins - pharmacology | Urinary Tract Infections - microbiology | Ampicillin - pharmacology | Escherichia coli Infections - drug therapy | Ciprofloxacin - pharmacology | Escherichia coli Infections - microbiology | Amikacin - pharmacology | Imipenem - pharmacology | Urinary Tract Infections - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology | Turkey | Uropathogenic Escherichia coli - drug effects | European Union | Disk Diffusion Antimicrobial Tests | Anti-Bacterial Agents - pharmacology | Microbial Sensitivity Tests - methods
Journal Article
Details down arrow
12. Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
by Cusack, T P and Ashley, E A and Ling, C L and Rattanavong, S and Roberts, T and Turner, P and Wangrangsimakul, T and Dance, D A B
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 07/2019, Volume 25, Issue 7, p. 910
Journal Article
Details down arrow
13. Full Text Comprehensive antimicrobial susceptibility testing of a large collection of clinical strains of Aggregatibacter actinomycetemcomitans does not identify resistance to amoxicillin
by Jensen, Anne B and Haubek, Dorte and Claesson, Rolf and Johansson, Anders and Nørskov‐Lauritsen, Niels
Journal of Clinical Periodontology, ISSN 0303-6979, 08/2019, Volume 46, Issue 8, pp. 846 - 854
Aim The present study aims to determine the susceptibility of Aggregatibacter actinomycetemcomitans to amoxicillin by investigating a large collection of oral... 
agar dilution method | β‐lactams | breakpoints | antimicrobial resistance | European Committee of Antimicrobial Susceptibility Testing | SYSTEMIC ANTIBIOTICS | O-POLYSACCHARIDE | AGGRESSIVE PERIODONTITIS | LEUKOTOXIC JP2 CLONE | ANTIBIOTIC-RESISTANCE | HAEMOPHILUS | AMPICILLIN | ACTINOBACILLUS-ACTINOMYCETEMCOMITANS | beta-lactams | SEROTYPE | DENTISTRY, ORAL SURGERY & MEDICINE | METRONIDAZOLE | Amoxicillin | Polymerase chain reaction | Antimicrobial agents | Carbon dioxide | Minimum inhibitory concentration
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Del CLSI al EUCAST, una transición necesaria en los laboratorios españoles
by Larrosa, María Nieves and Benito, Natividad and Cantón, Rafael and Canut, Andrés and Cercenado, Emilia and Fernández-Cuenca, Felipe and Guinea, Jesús and López-Navas, Antonio and Moreno, Miguel Ángel and Oliver, Antonio and Martínez-Martínez, Luis
Enfermedades Infecciosas y Microbiología Clínica, ISSN 0213-005X, 11/2018
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Time to switch from CLSI to EUCAST? A Southeast Asian perspective
by Cusack, T.P and Ashley, E.A and Ling, C.L and Roberts, T and Turner, P and Wangrangsimakul, T and Dance, D.A.B
Clinical Microbiology and Infection, ISSN 1198-743X, 07/2019, Volume 25, Issue 7, pp. 782 - 785
Journal Article
Details down arrow
16. CLSI'dan EUCAST'e Geçişte Üriner Sistem Enfeksiyonu Etkeni Escherichia coli Izolatlarinin Antibiyotik Duyarliliklarinin Karşilaştirilmasi
by Süzük, Serap and Kaşkatepe, Banu and Avciküçük, Havva and Aksaray, Sebahat and Başustaoʇlu, Ahmet
Mikrobiyoloji Bulteni, ISSN 0374-9096, 10/2015, Volume 49, Issue 4, pp. 494 - 501
Clinical Laboratory Standards Institute (CLSI) | Antibiotic susceptibility test | European Committee on Antimicrobial Susceptibility Testing (EUCAST) | Esherichia coli
Journal Article
Details down arrow
17. Comparison of susceptibility testing by EUCAST and CLSI broth microdilution methods against aspergillus isolates
by Zhang, Ming and Chen, Fei and Sun, Wenkui and Wu, Ting and Yan, Wenjie and Su, Xin and Shi, Yi
Chinese Journal of Infection and Chemotherapy, ISSN 1009-7708, 2014, Volume 14, Issue 4, pp. 338 - 343
Aspergillus | Minimum inhibitory concentration | Clinical and Laboratory Standards Institute | European committee on antimicrobial susceptibility testing | Minimum effective concentration
Journal Article
Details down arrow
18. Full Text Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data
by Cole, Michelle J and Quaye, Nerteley and Jacobsson, Susanne and Day, Michaela and Fagan, Elizabeth and Ison, Catherine and Pitt, Rachel and Seaton, Shila and Woodford, Neil and Stary, Angelika and Pleininger, Sonja and Crucitti, Tania and Hunjak, Blaženka and Maikanti, Panayiota and Hoffmann, Steen and Viktorova, Jelena and Buder, Susanne and Kohl, Peter and Tzelepi, Eva and Siatravani, Eirini and Balla, Eszter and Hauksdóttir, Gurún Svanborg and Rose, Lisa and Stefanelli, Paola and Carannante, Anna and Pakarna, Gatis and Mifsud, Francesca and Cassar, Rosann Zammit and Linde, Ineke and Bergheim, Thea and Steinbakk, Martin and Mlynarczyk-Bonikowska, Beata and Borrego, Maria-José and Shepherd, Jill and Pavlik, Peter and Jeverica, Samo and Vazquez, Julio and Abad, Raquel and Weiss, Sabrina and Spiteri, Gianfranco and Unemo, Magnus
BMC Infectious Diseases, ISSN 1471-2334, 03/2019, Volume 19, Issue 1, pp. 281 - 281
BackgroundConfidence in any diagnostic and antimicrobial susceptibility testing data is provided by appropriate and regular quality assurance (QA) procedures.... 
Euro-GASP | European Union (EU) | Gonorrhoea | European economic area (EEA) | EUCAST | AGAR DILUTION | INFECTIOUS DISEASES | ETEST | CEFTRIAXONE | MINIMUM INHIBITORY CONCENTRATION | SURVEILLANCE | RESISTANCE | MEDIA | CALIBRATED DICHOTOMOUS SENSITIVITY | DIFFUSION | ASSURANCE SCHEME | Disk Diffusion Antimicrobial Tests - standards | Reproducibility of Results | Microbial Sensitivity Tests - standards | Neisseria gonorrhoeae - drug effects | Laboratories | Europe | Drug Resistance, Bacterial | Anti-Bacterial Agents - pharmacology | Quality Control | Quality control | Performance evaluation | Breakpoints | Phenotypes | Curricula | Antimicrobial agents | Gonorrhea | Drug resistance | Antiinfectives and antibacterials | Quality assurance | Testing laboratories | Surveillance | Minimum inhibitory concentration | Diagnostic systems | Antimicrobial resistance | Quality assessment | Condoms | Public health | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro
by Cuenca-Estrella, Manuel and Rodriguez-Tudela, Juan Luis
Expert Review of Anti-Infective Therapy, ISSN 1478-7210, 03/2010, Volume 8, Issue 3, pp. 267 - 276
The role of antifungal susceptibility testing (AFST) reference procedures seems to be restricted to a number of uses and to being performed in reference... 
Antifungal epidemiological cut-off | CLSI | EUCAST | Antifungal breakpoint | antifungal epidemiological cut-off | ACTIVE SURVEILLANCE PROGRAM | AMPHOTERICIN-B | DISK DIFFUSION METHODS | antifungal breakpoint | FLUCONAZOLE SUSCEPTIBILITY | BROTH MICRODILUTION | SUSCEPTIBILITY TESTING EUCAST | EUROPEAN COMMITTEE | PHARMACOLOGY & PHARMACY | MONTE-CARLO-SIMULATION | CANDIDA SPP | BLOOD-STREAM INFECTIONS | Antifungal Agents - pharmacology | Mycoses - epidemiology | Microbial Sensitivity Tests - standards | Fungi - drug effects | Drug Resistance, Fungal - drug effects | Humans | Mycoses - drug therapy | Mycoses - microbiology | Reference Values | Yeasts - drug effects | Microbial Sensitivity Tests - methods | Antifungal Agents - standards | Indexing in process
Journal Article
Details down arrow
20. Full Text Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida : Time for harmonization of CLSI and EUCAST broth microdilution methods
by Pfaller, M.A and Andes, D and Diekema, D.J and Espinel-Ingroff, A and Sheehan, D and CLSI Subcomm Antifungal Susceptibi and CLSI Subcommittee for Antifungal Susceptibility Testing
Drug Resistance Updates, ISSN 1368-7646, 2010, Volume 13, Issue 6, pp. 180 - 195
Abstract Background Both the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST)... 
Infectious Disease | Hematology, Oncology and Palliative Medicine | Clinical and Laboratory Standards Institute (CLSI) | Fluconazole | European Committee on Antimicrobial Susceptibility Testing | Broth microdilution | Susceptibility Testing | OROPHARYNGEAL CANDIDIASIS | SURVEILLANCE-PROGRAM | European Committee on Antimicrobial | IN-VITRO SUSCEPTIBILITY | AMPHOTERICIN-B | HUMAN-IMMUNODEFICIENCY-VIRUS | AZOLE ANTIFUNGAL AGENTS | MESSENGER-RNA LEVELS | PHARMACOLOGY & PHARMACY | INFECTIOUS-DISEASES-SOCIETY | SMALL COLONY VARIANTS | MOLECULAR-MECHANISMS | Candida - genetics | Candida - metabolism | Fluconazole - pharmacology | Species Specificity | United States | Europe | Humans | Drug Resistance, Fungal - physiology | Candida - enzymology | Fluconazole - therapeutic use | Fluconazole - pharmacokinetics | Microbial Sensitivity Tests - standards | Candidiasis - drug therapy | Candida - drug effects | Microbial Sensitivity Tests - methods | Medical colleges | Epidemiology | Influenza | Methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights